Skip to main content

Advertisement

SpringerLink
Log in

Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis

  • Validation Studies
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The study aimed to translate and cross-culturally adapt the self-comorbidity questionnaire (SCQ) into Turkish and investigate the validity and reliability of SCQ and its modified version (mSCQ) in psoriatic arthritis (PsA). Psoriatic arthritis quality of life (PsAQoL) and short form 36 (SF-36) were used to assess the quality of life. The physical disability was evaluated with the health assessment questionnaire (HAQ). The reliability of the SCQ scale was assessed by test–retest reliability. For construct validity, the correlations of SCQ with the HAQ, SF-36, PsAQoL, age, body mass index (BMI), disease duration, disease activity in psa (DAPSA), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Psoriasis Area and Severity Index (PASI), dactylitis and enthesitis were evaluated. The mSCQ was also used by removing the items related to rheumatic conditions. For the test–retest reliability of the Turkish version of SCQ, the intraclass correlation coefficient was 0.965, p < 0.001. The SCQ and mSCQ had significant correlations with HAQ, PsAQoL, some subscales of SF-36, and age (p < 0.05), but not with disease duration, BASDAI, PASI and dactylitis (p > 0.05). Although SCQ had a low correlation with DAPSA (rho = 0.262, p = 0.031), mSCQ was not correlated with DAPSA (p > 0.05). mSCQ was significantly correlated with BMI (rho = 0.233, p = 0.016), but SCQ was not (p > 0.05). The Turkish version of SCQ had adequate reliability and validity, and the mSCQ improved the validity of the scale in patients with PsA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The datasets generated and analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Veale DJ, Fearon U (2018) The pathogenesis of psoriatic arthritis. Lancet 391:2273–2284. https://doi.org/10.1016/S0140-6736(18)30830-4

    Article  PubMed  CAS  Google Scholar 

  2. Gupta S, Syrimi Z, Hughes DM, Zhao SS (2021) Comorbidities in psoriatic arthritis: a systematic review and meta-analysis. Rheumatol Int 41:275–284. https://doi.org/10.1007/s00296-020-04775-2

    Article  PubMed  PubMed Central  Google Scholar 

  3. Perez-Chada LM, Merola JF (2020) Comorbidities associated with psoriatic arthritis: review and update. Clin Immunol 214:108397. https://doi.org/10.1016/j.clim.2020.108397

    Article  PubMed  CAS  Google Scholar 

  4. Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM (2020) Impact of comorbidities on disease activity, patient global assessment, and function in psoriatic arthritis: a cross-sectional study. Rheumatol Ther 7:825–836. https://doi.org/10.1007/s40744-020-00229-0

    Article  PubMed  PubMed Central  Google Scholar 

  5. Cañete JD, Tasende J, Laserna F, Castro SG, Queiro R (2020) The impact of comorbidity on patient-reported outcomes in psoriatic arthritis: a systematic literature review. Rheumatol Ther 7:237–257. https://doi.org/10.1007/s40744-020-00202-x

    Article  PubMed  PubMed Central  Google Scholar 

  6. Imamura K, McKinnon M, Middleton R, Black N (1997) Reliability of a comorbidity measure: the Index of Co-Existent Disease (ICED). J Clin Epidemiol 50:1011–1016. https://doi.org/10.1016/s0895-4356(97)00128-5

    Article  PubMed  CAS  Google Scholar 

  7. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383. https://doi.org/10.1016/0021-9681(87)90171-8

    Article  PubMed  CAS  Google Scholar 

  8. Olomu AB, Corser WD, Stommel M, Xie Y, Holmes-Rovner M (2012) Do self-report and medical record comorbidity data predict longitudinal functional capacity and quality of life health outcomes similarly? BMC Health Serv Res 12:398. https://doi.org/10.1186/1472-6963-12-398

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sangha O, Stucki G, Liang MH, Fossel AH, Katz JN (2003) The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum 49:156–163. https://doi.org/10.1002/art.10993

    Article  PubMed  Google Scholar 

  10. Oemrawsingh A, Swami N, Valderas JM, Hazelzet JA, Pusic AL, Gliklich RE, Bergmark RW (2020) Patient-reported morbidity instruments: a systematic review. Value Health 23:791–811. https://doi.org/10.1016/j.jval.2020.02.006

    Article  PubMed  Google Scholar 

  11. Stolwijk C, van Tubergen A, Ramiro S, Essers I, Blaauw M, van der Heijde D, Landewé R, van den Bosch F, Dougados M, Boonen A (2014) Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatol (Oxf) 53:1054–1064. https://doi.org/10.1093/rheumatology/ket354

    Article  Google Scholar 

  12. Baron M, Schieir O, Hudson M et al (2009) Evaluation of the clinimetric properties of the early inflammatory arthritis-self-administered comorbidity questionnaire. Rheumatol (Oxf) 48:390–394. https://doi.org/10.1093/rheumatology/ken504

    Article  Google Scholar 

  13. Stolwijkv C, Essers I, van den Bosch F, Dougados M, Etcheto A, van der Heijde D, Landewé R, Molto A, van Tubergen A, Boonen A, ASAS-COMOSPA Study Group (2020) Validation of the self-administered comorbidity questionnaire adjusted for spondyloarthritis: results from the ASAS-COMOSPA study. Rheumatol (Oxf) 59:1632–1639. https://doi.org/10.1093/rheumatology/kez482

    Article  Google Scholar 

  14. Pacheco-Brousseau L, Poitras S, Savard J, Varin D, Moreau G, Matar WY, Beaulé P (2020) Development of the French-Canadian version of the self-administered comorbidities questionnaire (SCQ) in a hospital population undergoing hip or knee arthroplasty. Orthop Traumatol Surg Res 106:557–561. https://doi.org/10.1016/j.otsr.2019.12.022

    Article  PubMed  Google Scholar 

  15. Streibelt M, Schmidt C, Brünger M, Spyra K (2012) Komorbidität im Patientenurteil—geht das? Validität eines Instruments zur Selbsteinschätzung der Komorbidität (SCQ-D) [Comorbidity from the patient perspective—does it work? Validity of a questionnaire on self-estimation of comorbidity (SCQ-D)]. Orthopade 41:303–310. https://doi.org/10.1007/s00132-012-1901-3

    Article  PubMed  CAS  Google Scholar 

  16. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group (2006) Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 54:2665–2673. https://doi.org/10.1002/art.21972

    Article  PubMed  Google Scholar 

  17. Anthoine E, Moret L, Regnault A, Sébille V, Hardouin JB (2014) Sample size used to validate a scale: a review of publications on newly-developed patient-reported outcomes measures. Health Qual Life Outcomes 12:176. https://doi.org/10.1186/s12955-014-0176-2

    Article  PubMed  Google Scholar 

  18. Feldman SR, Fleischer AB Jr, Reboussin DM, Rapp SR, Exum ML, Clark AR, Nurre L (1996) The self-administered psoriasis area and severity index is valid and reliable. J Invest Dermatol 106:183–186. https://doi.org/10.1111/1523-1747.ep12329912

    Article  PubMed  CAS  Google Scholar 

  19. Healy PJ, Helliwell PS (2008) Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 59:686–691. https://doi.org/10.1002/art.23568

    Article  PubMed  Google Scholar 

  20. Fries JF, Spitz P, Kraines RG, Holman HR (1980) Measurement of patient outcome in arthritis. Arthritis Rheum 23:137–145. https://doi.org/10.1002/art.1780230202

    Article  PubMed  CAS  Google Scholar 

  21. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ (2004) Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 63:162–169. https://doi.org/10.1136/ard.2003.006296

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30:473–483

    Article  Google Scholar 

  23. Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191. https://doi.org/10.1097/00007632-200012150-00014

    Article  PubMed  CAS  Google Scholar 

  24. Koo TK, Li MY (2016) A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 15:155–163. https://doi.org/10.1016/j.jcm.2016.02.012

    Article  PubMed  PubMed Central  Google Scholar 

  25. Misra DP, Zimba O, Gasparyan AY (2021) Statistical data presentation: a primer for rheumatology researchers. Rheumatol Int 41:43–55. https://doi.org/10.1007/s00296-020-04740-z

    Article  PubMed  Google Scholar 

  26. Bonett DG (2002) Sample size requirements for estimating intraclass correlations with desired precision. Stat Med 21:1331–1335. https://doi.org/10.1002/sim.1108

    Article  PubMed  Google Scholar 

  27. Schober P, Boer C, Schwarte LA (2018) Correlation coefficients: appropriate use and interpretation. Anesth Analg 126:1763–1768. https://doi.org/10.1213/ANE.0000000000002864

    Article  PubMed  Google Scholar 

  28. Hudson M, Bernatsky S, Taillefer S et al (2008) Patients with systemic autoimmune diseases could not distinguish comorbidities from their index disease. J Clin Epidemiol 61:654–662. https://doi.org/10.1016/j.jclinepi.2007.08.010

    Article  PubMed  Google Scholar 

  29. Hitchon CA, Boire G, Haraoui B et al (2016) Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis Cohort. Rheumatol (Oxf) 55:1751–1762. https://doi.org/10.1093/rheumatology/kew061

    Article  Google Scholar 

  30. Ursum J, Korevaar JC, Twisk JW, Peters MJ, Schellevis FG, Nurmohamed MT, Nielen MM (2013) Prevalence of chronic diseases at the onset of inflammatory arthritis: a population-based study. Fam Pract 30:615–620. https://doi.org/10.1093/fampra/cmt037

    Article  PubMed  Google Scholar 

  31. Fernández-Carballido C, Martín-Martínez MA, García-Gómez C et al (2020) Impact of comorbidity on physical function in patients with ankylosing spondylitis and psoriatic arthritis attending rheumatology clinics: results from a cross-sectional study. Arthrit Care Res (Hoboken) 72:822–828. https://doi.org/10.1002/acr.23910

    Article  CAS  Google Scholar 

  32. Sinnathurai P, Buchbinder R, Hill C, Lassere M, March L (2018) Comorbidity in psoriatic arthritis and rheumatoid arthritis. Intern Med J 48:1360–1368. https://doi.org/10.1111/imj.14046

    Article  PubMed  CAS  Google Scholar 

  33. Bavière W, Deprez X, Houvenagel E, Philippe P, Deken V, Flipo RM, Paccou J (2020) Association between comorbidities and quality of life in psoriatic arthritis: results from a multicentric cross-sectional study. J Rheumatol 47:369–376. https://doi.org/10.3899/jrheum.181471

    Article  PubMed  Google Scholar 

  34. Fragoulis GE, Nikiphorou E, McInnes IB, Siebert S (2021) Does age matter in psoriatic arthritis? A narrative review. J Rheumatol. https://doi.org/10.3899/jrheum.210349

    Article  PubMed  Google Scholar 

  35. Queiro R, Lorenzo A, Tejón P, Coto P, Pardo E (2019) Obesity in psoriatic arthritis: comparative prevalence and associated factors. Med (Baltim) 98(28):e16400. https://doi.org/10.1097/MD.0000000000016400

    Article  Google Scholar 

  36. Kumthekar A, Ogdie A (2020) Obesity and psoriatic arthritis: a narrative review. Rheumatol Ther 7:447–456. https://doi.org/10.1007/s40744-020-00215-6

    Article  PubMed  PubMed Central  Google Scholar 

  37. Mease PJ, Karki C, Palmer JB et al (2017) Clinical characteristics, disease activity, and patient-reported outcomes in psoriatic arthritis patients with dactylitis or enthesitis: results from the corrona psoriatic arthritis/spondyloarthritis registry. Arthrit Care Res (Hoboken) 69:1692–1699. https://doi.org/10.1002/acr.23249

    Article  CAS  Google Scholar 

Download references

Acknowledgements

None.

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Rheumatology Clinic, Prof. Dr. Cemil Taşcıoğlu City Hospital, Istanbul, Turkey

    Didem Erdem Gürsoy

  2. Rheumatology Clinic, Ümraniye Research and Training Hospital, Istanbul, Turkey

    Halise Hande Gezer

  3. Rheumatology Clinic, Dr. Lüfti Kırdar Research and Training Hospital, Istanbul, Turkey

    Sevtap Acer Kasman

  4. Department of Physical Medicine and Rehabilitation, Rheumatology Division, Marmara University Faculty of Medicine, Istanbul, Turkey

    Mehmet Tuncay Duruöz

Authors
  1. Didem Erdem Gürsoy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Halise Hande Gezer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sevtap Acer Kasman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehmet Tuncay Duruöz
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study design, material preparation, data collection, analysis, interpretation and writing of the manuscript and take full responsibility for the integrity of the study and the final manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Didem Erdem Gürsoy.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Ethical approval

The study was approved by the Ethical Committee of Marmara University Faculty of Medicine (insert number: 09.2018.731 and date of approval: 02.11.2018).

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Erdem Gürsoy, D., Gezer, H.H., Acer Kasman, S. et al. Validity and psychometric characteristics of the self-administered comorbidity questionnaire in patients with psoriatic arthritis. Rheumatol Int 42, 2061–2067 (2022). https://doi.org/10.1007/s00296-022-05150-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-022-05150-z

Keywords

Search

Navigation